Su CM

No ORCID on file · 4 papers in corpus · active 2014-2020
2020
Impacts of RETN genetic polymorphism on breast cancer development.
Journal of Cancer ·doi:10.7150/jca.38088

The adipokine resistin is linked with obesity, inflammation and various cancers, including breast cancer. This study sought to determine whether certain polymorphisms in the gene encoding resistin, RETN, increase the risk of breast cancer s…

2019
Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer.
Medicine ·doi:10.1097/md.0000000000017854

Breast cancer is the most common diagnosed malignancy in women. This study genotyped blood samples from 236 Han Chinese women with breast cancer and 128 healthy controls for single nucleotide polymorphisms (SNPs) rs2977537, rs2929970, rs292…

2018
Correlation between CCL4 gene polymorphisms and clinical aspects of breast cancer.
International journal of medical sciences ·doi:10.7150/ijms.26771

Breast cancer is a major cause of cancer mortality amongst women. Chemokine (C-C motif) ligand 4 is encoded by the CCL4 gene; specific CCL4 gene polymorphisms are related to the risks and prognoses of various diseases. In this study, we exa…

2014
Comparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: a systematic review and meta-analysis.
PloS one ·doi:10.1371/journal.pone.0106854

ObjectiveTo evaluate the effectiveness and safety of GnRH antagonist and GnRH agonist in supposed normal ovarian responders undergoing IVF.MethodsData from 6 databases were retrieved for this study. The RCTs of GnRH agonist and GnRH antagon…